Advanced Treatments & Technologies
Dr. Xingyu Cao: CD7 CAR-T Combined with Allogen...
Dr. Xingyu Cao’s groundbreaking research shows that CD7 CAR-T therapy combined with allo-HSCT significantly improves long-term survival in patients with relapsed/refractory T-ALL and T-LBL. The study, published in BJH, highlights...
Dr. Xingyu Cao: CD7 CAR-T Combined with Allogen...
Dr. Xingyu Cao’s groundbreaking research shows that CD7 CAR-T therapy combined with allo-HSCT significantly improves long-term survival in patients with relapsed/refractory T-ALL and T-LBL. The study, published in BJH, highlights...
Over 10,000 Hematopoietic Stem Cell Transplants...
On April 19, 2024, Ludaopei Hospital achieved a remarkable milestone by performing its 10,000th hematopoietic stem cell transplant. This achievement highlights the hospital's role as a leader in stem cell...
Over 10,000 Hematopoietic Stem Cell Transplants...
On April 19, 2024, Ludaopei Hospital achieved a remarkable milestone by performing its 10,000th hematopoietic stem cell transplant. This achievement highlights the hospital's role as a leader in stem cell...